Topic: Pfizer Inc.
The headline on Celldex Therapeutics' (Nasdaq: CLDX) press release sounds rather promising: "Celldex Therapeutics Regains Worldwide Rights to...
By Shannon Pettypiece . Pfizer Inc. is pulling out of an agreement with Celldex Therapeutics Inc. to fund the development of an experimental brain ...
Partnership Travel Consulting has named Philip Dunphy as its senior vice president.. . "I am very excited to have someone of Phil's caliber join...
Is Pfizer (NYSE: PFE) folding on making acquisition deals? That seems to be a trick question as the drug giant announced the purchase of FoldRx...
Numbers can lie -- but they're the best first step in determining whether a stock is a buy. In this series, we use some carefully chosen metrics to...
Almost half of Americans took at least one prescription drug per month in 2008, an increase of 10 percent over the past decade, a U.S. study found...
File this under back to the drawing board. The Superior Court of Pennsylvania has decided that lawsuits filed by 14 women against Pfizer's Wyeth...
The battle to prevent blood clots is heating up this week as several drugmakers begin releasing study results for their experimental drugs. At...
Two years ago, the Pharmac government agency in New Zealand, which is responsible for subsidizing meds, declined funding for Pfizer's Chantix...
Aaron Lynett/National Post. A scale model of North America's tallest flagpole that will be constructed in Emery Village sits in the office of City...